Evaluation of an Immunomodulatory Maintenance Treatment in Patients With Metastatic Colorectal Cancer With Tumor Reduction During Induction Treatment
Status: Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 09 Oct 2019
Price : $35 *
At a glance
- Drugs Lefitolimod (Primary)
- Indications Colorectal cancer
- Focus Registrational; Therapeutic Use
- Acronyms IMPALA
- Sponsors Mologen
- 06 Oct 2019 This trial has been discontiued in Spain, according to European Clinical Trials Database record.
- 24 Sep 2019 This trial has been completed in Austria, Germany,Estonia according to European Clinical Trials Database.
- 05 Aug 2019 According to a Mologen media release, the detailed data from this first top line analysis of the this trial will be submitted for presentation at an upcoming international scientific congress.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History